Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis SurveyDaniele Santini, Nicola Silvestris, Francesco Pantano et al.|PLoS ONE|2014Cited by 50
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III studyVito Lorusso, Giuseppe Colucci, Francesco Giotta et al.|International Journal of Oncology|2014Cited by 26
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patientsAlessandra Fabi, F. Cognetti, G. Ferretti et al.|Cancer Chemotherapy and Pharmacology|2005Cited by 20
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experienceMariangela Ciccarese, Giammarco Surico, Laura Isabella Lupo et al.|Breast Cancer Research and Treatment|2017Cited by 12
Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group StudyPasquale Comella, Giuseppe Comella, Nicola Panza et al.|Clinical Lung Cancer|2000Cited by 10